期刊文献+

雌二醇对子宫内膜癌细胞MAPK通路的激活及其对增殖与迁移的影响 被引量:3

Activation of MAPK signaling pathway through estradiol and its effects on proliferation and migration in endometrial cancer cells
下载PDF
导出
摘要 目的:探讨雌激素能否激活MAPK信号通路,及对子宫内膜癌细胞增殖能力的影响。方法:(1)不同浓度雌二醇作用于HEC-1A细胞后,蛋白印迹法检测p-ERK1/2蛋白活化水平。(2)实验分3组:E2组、U0126+E2组、对照组。荧光定量PCR技术检测细胞中MEK1/2、ERK1/2 m RNA的表达,蛋白印迹法检测p-MEK1/2、p-ERK1/2蛋白活化水平。(3)流式细胞仪,体外穿膜及细胞集落形成实验。结果:(1)不同浓度的E2作用细胞后,蛋白活化水明显高于对照组(P<0.05)。(2)蛋白活化水平E2组均高于对照组(P<0.05);U0126+E2组均低于E2组(P<0.05)。(3)G1期及S期细胞比例;穿过微孔的细胞数;集落形成率U0126+E2组与E2组,E2组与对照组比较,差异均有统计学意义(P<0.05)。结论 :雌二醇通过激活MAPK通路,促进子宫内膜癌的发生、发展。 Objective To explore whether estradiol can activate MAPK(mitogen activated protein kinase)pathway and its effect on the proliferation and migration in endometrial cancer cells. Methods There were 3groups including E2 group, U0126 + E2 group and control group. p-ERK1 / 2 protein expression was detected by Western blot after stimulation of HEC-1A with different concentrations of estradiol. q RT-PCR and western blot were used to detect m RNA expression of MEK1 / 2 and ERK1 / 2 and protein of p-ERK1 / 2 and p-MEK1 / 2. Flow cytometry, transwell assay and colony formation were applied as well. Results The expression of p-ERK1 / 2protein was significantly higher in E2 group than that in control group(P 〈0.05). The expressions of m RNA and protein of MEK1 / 2 and ERK1 / 2 were higher in E2 group than that in control group, but those in U0126 + E2 group were lower than that in control group(P 〈0.05). The percentage of HEC-1A in G1 phase and S phase, the cell number of migration and the colony forming rate in E2 group were higher than those in control group(P 〈0.05), and those in U0126 + E2 group were lower than those in E2 group(P 〈0.05). Conclusion Estradiol can activate MAPK pathway, further promote the development of endometrial cancer cells.
出处 《实用医学杂志》 CAS 北大核心 2016年第2期181-185,共5页 The Journal of Practical Medicine
基金 国家自然科学基金项目(编号:81160318) 广西自然科学基金项目(编号:2013GXNSFAA019219)
关键词 子宫内膜肿瘤 雌二醇 MAPK通路 Endometrial adenocarcinoma Eestradiol MAPK
  • 相关文献

参考文献11

  • 1MIZUMOTO Y, KYO S, MORl N, et al. Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial and is associated with favorable prognosis [J]. Cance Sci, 2007, 98(5) :652-658.
  • 2卢燕琼,蒋斯,张洁清,宋红林,李力.雌二醇诱导子宫内膜癌细胞产生的VEGF和bFGF对MAPK通路的影响[J].中华妇产科杂志,2014,49(12):925-931. 被引量:14
  • 3ZHANG L, LI X, ZHAO L, et al. Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells [J]. J Cell Biochem, 2009, 106 (4) : 553- 562.
  • 4SADARIA MR, YU JA, MENG X, et al. Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway [J]. Anticancer Res, 2013, 33( 4): 1337-1342.
  • 5屈小勇,王毅,秦春宏.U0126对imDC诱导初始性CD4^+T细胞的体外研究[J].实用医学杂志,2010,26(24):4476-4479. 被引量:2
  • 6TREECK 0, DIEDRICH K, ORTMANN O. The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines [J]. Eur J Cancer, 2003,39(9): 1302-1309.
  • 7SUN Y, WANG C, YANG H, et al. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERR-y through AKT and ERKI/2 [J]. Eur J Cancer Prev , 2014,23(5): 418-24.
  • 8ZHOU C, STEPLOWSKI TA, DICKENS HK, et al. Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells [J]. PLoS One, 2013,8 (2): e55730.
  • 9THOMAS RS, SARWAR N, PHOENIX F, et al. Phosphorylation at serines 104 and 106 by Erk 112 MAPK is important for estrogen receptor-alpha activity [J]. J Mol Endocrinol , 2008,40 (4) :173-184.
  • 10ZHANG H, ZHAO X, YAN L, et al. Similar expression to FGF (Sef ) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway [J]. Gynecol Oncol, 2011,122(3) :669-674.

二级参考文献14

  • 1Appleman L J,Tzachanis D,Grader-Beck T,et al.Helper T cell anergy:from biochemistry to cancer pathophysiology and therapeutics[J].J Exp Med,2008,78(12):673-683.
  • 2Calvo c R,Amsen D,Kruisbeek A M.Cytotoxic T lymphocyte antigen 4(CTLA-4) interferes with extracellular singnal-regulated kinase(ERK)and Jun NH2-terminal kinase (JNK)activation,but does not affect phosphorylation of T cell receptor zeta and ZAP70[J].J Exp Med,2005,186(10):1645-1653.
  • 3Xu W,Yan M,Lu L,et al.The P38 MAPK pathway is involved in the IL-2 induction of TNF-beta gene via to EBS element[J].Biochem Biophys Res Commun,2008,289(5):979-986.
  • 4Goldfarb A N,Delehanty L L,Wang D,et al.Stromal inhibition of megakaryocytic differentiation correlates with blockade of signaling by protein kinase C epsion and ERK/MAPK[J].J Biol Chem,2007,276(31):29526-29530.
  • 5Rossini A A,Greiner D L,Mordes J P,Induction of immunologic tolerance for transplantation[J].Physic Bev,2009,79(1):99-141.
  • 6Cannons J L,Choi Y,Watts T H,Role of TNF receptor-associated factor 2 and P38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response[J].J Immunol,2007,165(11):6193-6204.
  • 7Ortega E, Marti RM, Yeramian A, et al. Targeted therapies in gynecologic cancers and melanoma[J]. Semin Diagn Pathol, 2008,25:262-273.
  • 8Gozgit JM, Squillace RM, Wongchenko MJ, et al. Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models[J]. Cancer Chemother Pharmacol, 2013,71:1315-1323.
  • 9Treeck O, Diedrich K, Ortmann O. The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines[J].Eur J Cancer, 2003, 39:1302-1309.
  • 10Suga S, Kato K, Ohgami T, et al. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer[J]. Gynecol Oncol, 2007, 105:341-350.

共引文献14

同被引文献28

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部